Clinical Trial

Outcomes and Perceptions of the Implementation of the JADA Device in a Stage II Postpartum Hemorrhage Management Protocol in Referral Hospitals of the Colombian Pacific Region

Study acronym: JADAValle
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study focuses on postpartum hemorrhage (PPH), a condition that stands out as the leading cause of global maternal mortality. Annually, about 14 million women experience PPH, resulting in approximately 70,000 deaths. This condition presents a higher risk in low- and middle-income countries (LMICs), particularly where access to quality care is limited. Recognizing the urgency of addressing this public health problem, the Colombian Ministry of Health and Social Protection has implemented the Maternal Mortality Reduction Acceleration Plan (PARE) to improve maternal mortality indicators and meet the Sustainable Development Goals (SDGs). The project will evaluate the results and perception of a new device in the management of stage II PPH in referral hospitals in the department of Valle del Cauca, integrated in the Hospital Padrino strategy. This initiative seeks not only to improve the understanding and treatment of PPH, but also to strengthen institutional capacities through education, creation of telecare networks and care services adapted to local needs.
Trial Details
NCT Number NCT06843265
Lead Sponsor Fundacion Clinica Valle del Lili
Collaborators: Hospital Universitario del Valle Evaristo Garcia
Conditions Post Partum Haemorrhage
Enrollment 24 participants
Start Date 2025-06-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-24